Treatment Delay in Melanoma: A Risk Factor Analysis of an Impending Crisis
| Autor: | Marcus L, Elias, Ann M, John, Spandana, Maddukuri, Robert A, Schwartz, W Clark, Lambert |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Oncology
medicine.medical_specialty Skin Neoplasms Time-to-Treatment 030207 dermatology & venereal diseases 03 medical and health sciences 0302 clinical medicine Risk Factors hemic and lymphatic diseases Internal medicine Tumor stage Humans Medicine Risk factor Melanoma neoplasms Retrospective Studies business.industry Treatment delay Cancer Retrospective cohort study Middle Aged medicine.disease respiratory tract diseases Head and Neck Neoplasms 030220 oncology & carcinogenesis Cutaneous melanoma Female Factor Analysis Statistical business therapeutics |
| Zdroj: | Cutis. |
| DOI: | 10.12788/cutis.0235 |
| Popis: | Risk factors associated with melanoma treatment delay (MTD) have been inadequately studied. To elucidate MTD associations based on patient and tumor characteristics, a retrospective cohort study was performed for cutaneous melanoma cases reported to the National Cancer Database (NCDB) between 2004 and 2015. We evaluated the number of days from diagnosis to treatment initiation, analyzing postponements more than 45 days as moderate MTD (mMTD) and postponements more than 90 days as severe MTD (sMTD). Greater MTD rates were independently associated with patients who are older than 50 years, female, nonwhite, not privately insured, and treated at an academic facility and who have more advanced tumor stage and head/neck primaries. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|